Avanos Medical, Inc. (AVNS)
Free
No email, no account, no signup.
Pulling latest news for Avanos Medical, Inc.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NYSE
Type
Industrials
Sector
Medical technology and devices
Market Cap
$1.2B
We're already tracking Avanos Medical, Inc. — here are the latest events we've registered
Recent News
- On April 14, 2026, Avanos announced a definitive agreement to be acquired by American Industrial Partners in an all-cash transaction valued at approximately $1.272 billion. The company subsequently reported first-quarter 2026 results on May 5, 2026, featuring net sales of $182.2 million, an 8.8% year-over-year increase. The acquisition is expected to result in the company's delisting from the New York Stock Exchange upon completion.
Want to know how this news affects Avanos Medical, Inc.? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Avanos Medical, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.